Literature DB >> 29771793

Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes.

Jessica S Merlin1, Dustin Long2, William C Becker, Edward R Cachay3, Katerina A Christopoulos4, Kasey Claborn5, Heidi M Crane6, E Jennifer Edelman7, Richard Harding8, Stefan G Kertesz9, Jane M Liebschutz1, W Christopher Mathews3, Michael J Mugavero10, Sonia Napravnik11, Connall C OʼCleirigh, Michael S Saag10, Joanna L Starrels12, Robert Gross13.   

Abstract

BACKGROUND: Chronic pain occurs in up to 85% of persons living with HIV and is commonly treated with long-term opioid therapy (LTOT). We investigated the impact of chronic pain and LTOT on HIV outcomes.
METHODS: This was prospective cohort study conducted between July 2015 and July 2016 in 5 HIV primary care clinics. Chronic pain was defined as ≥moderate pain for ≥3 months on the Brief Chronic Pain Questionnaire. Chronic pain and LTOT were assessed at an index visit. Suboptimal retention, defined as at least one "no-show" to primary care, and virologic failure were measured over the subsequent year. Multivariable logistic regression models were built for each outcome adjusting for site.
RESULTS: Among 2334 participants, 25% had chronic pain, 27% had suboptimal retention, 12% had virologic failure, and 19% were prescribed LTOT. Among individuals not on LTOT, chronic pain was associated with increased odds of suboptimal retention [adjusted odds ratio (aOR) 1.46, 95% confidence interval (CI): 1.10 to 1.93, P = 0.009] and virologic failure (aOR 1.97, 95% CI: 1.39 to 2.80, P < 0.001). Among individuals with chronic pain, there was no association between LTOT and retention, but LTOT was associated with lower rates of virologic failure (aOR 0.56, 95% CI: 0.33 to 0.96, P = 0.03).
CONCLUSIONS: Chronic pain in participants not on LTOT was associated with virologic failure. This reinforces the need to identify effective chronic pain treatments for persons living with HIV and investigate their impact on HIV outcomes. The apparent protective association between LTOT and virologic failure in those with pain merits further exploration.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29771793      PMCID: PMC6092197          DOI: 10.1097/QAI.0000000000001741

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  28 in total

1.  Predictors of attrition in HIV-positive subjects with peripheral neuropathic pain.

Authors:  L Davis; S Evans; B Fishman; A Haley; L A Spielman
Journal:  AIDS Care       Date:  2004-04

2.  Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy.

Authors:  Fiona C Lampe; Richard Harding; Colette J Smith; Andrew N Phillips; Margaret Johnson; Lorraine Sherr
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

3.  Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.

Authors:  David Al Newcombe; Rachel E Humeniuk; Robert Ali
Journal:  Drug Alcohol Rev       Date:  2005-05

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

5.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

Review 6.  Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models.

Authors:  Peter R Kamerman; Philippa J Moss; Juliane Weber; Victoria C J Wallace; Andrew S C Rice; Wenlong Huang
Journal:  J Peripher Nerv Syst       Date:  2012-03       Impact factor: 3.494

7.  Quantitative Evaluation of an Instrument to Identify Chronic Pain in HIV-Infected Individuals.

Authors:  Jessica S Merlin; Andrew O Westfall; Eric Chamot; Michael Saag; Melonie Walcott; Christine Ritchie; Stefan Kertesz
Journal:  AIDS Res Hum Retroviruses       Date:  2015-03-12       Impact factor: 2.205

8.  Pain treatment and antiretroviral medication adherence among vulnerable HIV-positive patients.

Authors:  Hilary L Surratt; Steven P Kurtz; Maria A Levi-Minzi; Theodore J Cicero; Kiyomi Tsuyuki; Catherine L O'Grady
Journal:  AIDS Patient Care STDS       Date:  2014-07-01       Impact factor: 5.078

9.  Impact of illicit opioid use on T cell subsets among HIV-infected adults.

Authors:  E Jennifer Edelman; Kaku So-Armah; Debbie M Cheng; Margaret F Doyle; Sharon M Coleman; Carly Bridden; Natalia Gnatienko; Dmitry A Lioznov; Elena Blokhina; Matthew S Freiberg; Evgeny M Krupitsky; Brinda Emu; Jeffrey H Samet
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

10.  Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference.

Authors:  Erin E Krebs; Karl A Lorenz; Matthew J Bair; Teresa M Damush; Jingwei Wu; Jason M Sutherland; Steven M Asch; Kurt Kroenke
Journal:  J Gen Intern Med       Date:  2009-05-06       Impact factor: 5.128

View more
  19 in total

1.  Enhanced facilitation and diminished inhibition characterizes the pronociceptive endogenous pain modulatory balance of persons living with HIV and chronic pain.

Authors:  Michael A Owens; Romy Parker; Rachael L Rainey; Cesar E Gonzalez; Dyan M White; Anooshah E Ata; Jennifer I Okunbor; Sonya L Heath; Jessica S Merlin; Burel R Goodin
Journal:  J Neurovirol       Date:  2018-11-09       Impact factor: 2.643

2.  Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study - a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV.

Authors:  Marlene C Lira; Judith I Tsui; Jane M Liebschutz; Jonathan Colasanti; Christin Root; Debbie M Cheng; Alexander Y Walley; Meg Sullivan; Christopher Shanahan; Kristen O'Connor; Catherine Abrams; Leah S Forman; Christine Chaisson; Carly Bridden; Melissa C Podolsky; Kishna Outlaw; Catherine E Harris; Wendy S Armstrong; Carlos Del Rio; Jeffrey H Samet
Journal:  HIV Res Clin Pract       Date:  2019-04

3.  Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People Living With HIV and Chronic Pain.

Authors:  Jessica S Merlin; Dustin Long; William C Becker; Edward R Cachay; Katerina A Christopolous; Kasey R Claborn; Heidi M Crane; Eva Jennifer Edelman; Travis I Lovejoy; William Christopher Mathews; Benjamin J Morasco; Sonia Napravnik; Connall OʼCleirigh; Michael S Saag; Joanna L Starrels; Robert Gross; Jane M Liebschutz
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

4.  Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV.

Authors:  Lisa R LaRowe; John D Cleveland; Dustin M Long; Shadi Nahvi; Edward R Cachay; Katerina A Christopoulos; Heidi M Crane; Karen Cropsey; Sonia Napravnik; Conall O'Cleirigh; Jessica S Merlin; Joseph W Ditre
Journal:  AIDS Care       Date:  2021-02-17

5.  Marijuana Use and Its Associations With Pain, Opioid Dose, and HIV Viral Suppression Among Persons Living With HIV on Chronic Opioid Therapy.

Authors:  Jessica S Merlin; Jeffrey H Samet; Debbie M Cheng; Marlene C Lira; Judith I Tsui; Leah S Forman; Jonathan Colasanti; Alexander Y Walley; Carlos Del Rio; Jane M Liebschutz
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.771

6.  Race and satisfaction with pain management among patients with HIV receiving long-term opioid therapy.

Authors:  Anisha P Ganguly; Marlene C Lira; Sara Lodi; Leah S Forman; Jonathan A Colasanti; Emily C Williams; Jane M Liebschutz; Carlos Del Rio; Jeffrey H Samet; Judith I Tsui
Journal:  Drug Alcohol Depend       Date:  2021-03-18       Impact factor: 4.852

7.  Food insecurity and substance use in people with HIV infection and substance use disorder.

Authors:  Akila Raja; Timothy C Heeren; Alexander Y Walley; Michael R Winter; Aldina Mesic; Richard Saitz
Journal:  Subst Abus       Date:  2020-05-06       Impact factor: 3.716

8.  Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV.

Authors:  Judith I Tsui; Mary A Akosile; Gwen T Lapham; Denise M Boudreau; Eric A Johnson; Jennifer F Bobb; Ingrid A Binswanger; Bobbi Jo H Yarborough; Joseph E Glass; Rebecca C Rossom; Mark T Murphy; Chinazo O Cunningham; Julia H Arnsten; Manu Thakral; Andrew J Saxon; Joseph O Merrill; Jeffrey H Samet; Gavin B Bart; Cynthia I Campbell; Amy M Loree; Angela Silva; Angela L Stotts; Brian Ahmedani; Jordan M Braciszewski; Rulin C Hechter; Thomas F Northrup; Viviana E Horigian; Katharine A Bradley
Journal:  J Gen Intern Med       Date:  2021-02-10       Impact factor: 5.128

9.  Chronic High Risk Prescription Opioid Use Among Persons With HIV.

Authors:  Ana Ventuneac; Gavriella Hecht; Emily Forcht; Bianca A Duah; Shafaq Tarar; Blanche Langenbach; Jay Gates; Demetria Cain; H Jonathon Rendina; Judith A Aberg; David C Perlman
Journal:  Front Sociol       Date:  2021-05-18

Review 10.  People living with HIV and the emerging field of chronic pain-what is known about epidemiology, etiology, and management.

Authors:  Deepika E Slawek
Journal:  Curr HIV/AIDS Rep       Date:  2021-05-27       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.